About Joslin Research
Pathways of Discovery: Innovative Approaches in Diabetes Research
Joslin’s research team represents the most comprehensive and dynamic research program dedicated exclusively to diabetes anywhere in the world. Nowhere else can you find under one roof such a breadth of research knowledge and treatment expertise dedicated solely to diabetes.
From developmental and stem cell biology, to the interface between diabetes and genetics, to the role of inflammation in diabetes, the more than 300 scientists at Joslin are dedicated to pursuing innovative pathways of discovery to prevent, treat and cure type 1 and type 2 diabetes and their complications, with the ultimate goal of conquering diabetes in all of its forms.
Our academic model enables basic researchers and clinicians to forge a bond that fosters creative thinking and spurs discovery. Insights gained from Joslin’s laboratories improve clinical care (from the “bench to the bedside”) not only for Joslin patients, but for people with diabetes across the globe.
Some of the most important historical discoveries and improvements in diabetes care worldwide—recognition that tight blood glucose control can slow or prevent diabetes complications, creation of treatment protocols to enable women with diabetes to have healthy babies, the identification of markers for pre-diabetes, and pioneering laser surgery for diabetic eye disease—were developed at Joslin.
Joslin researchers have won top awards and recognition from the National Academy of Sciences, the Institute of Medicine, the American Diabetes Association (ADA) and the Juvenile Diabetes Research Foundation (JDRF), among many others. The number of papers Joslin researchers present each year at the annual ADA Scientific Sessions surpasses any other organization. Joslin also offers one of the largest research training programs in the world, with more than 120 M.D. and Ph.D. fellows training at the center annually.
To learn more about Joslin Research, visit the Research & Discovery section of our site.
Page last updated: April 21, 2019